Icon (ICLR) Change in Receivables (2009 - 2026)
Icon's (ICLR) quarterly Change in Receivables came in at -$43.5 million in Q2 2026, down 396.84% year-over-year from $14.7 million in Q2 2025, and down 1265.75% quarter-over-quarter from -$3.2 million in Q1 2026.
Analysis
Icon (ICLR) Change in Receivables (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Change in Receivables for 18 consecutive years, with -$43.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Receivables fell 396.84% year-over-year to -$43.5 million in Q2 2026; TTM through Jun 2026 was -$170.1 million, a 214.14% decrease from a year earlier, with the FY2025 full-year figure at -$108.2 million, down 132.53% from the prior year.
- Change in Receivables was -$43.5 million for Q2 2026 at Icon, down from -$3.2 million in the prior quarter.
- Over five years, Change in Receivables peaked at $279.2 million in Q2 2024 and troughed at -$279.9 million in Q4 2022.
- A 5-year average of -$16.7 million and a median of -$17.2 million in 2024 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables slumped 2727.63% in 2022 and soared 1043.89% in 2023, its largest moves.
- Over 5 years, Change in Receivables stood at -$279.9 million in 2022, then surged by 129.19% to $81.7 million in 2023, then tumbled by 124.69% to -$20.2 million in 2024, then plunged by 441.29% to -$109.2 million in 2025, then soared by 60.14% to -$43.5 million in 2026.
- The last three Change in Receivables figures came in at -$43.5 million (Q2 2026), -$3.2 million (Q1 2026), and -$109.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 47.18 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -43.54 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 21.82 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -3.71 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 414,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 416,693.85 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -43.54 Mn |
| Mar 31, 2026 | -3.19 Mn |
| Dec 31, 2025 | -109.23 Mn |
| Sep 30, 2025 | -14.14 Mn |
| Jun 30, 2025 | 14.67 Mn |
| Mar 31, 2025 | 481,000.00 |
| Dec 31, 2024 | -20.18 Mn |
| Sep 30, 2024 | 154.05 Mn |
| Jun 30, 2024 | 279.18 Mn |
| Mar 31, 2024 | -80.43 Mn |
| Dec 31, 2023 | 81.72 Mn |
| Sep 30, 2023 | -98.42 Mn |
| Jun 30, 2023 | 52.58 Mn |
| Mar 31, 2023 | -93.26 Mn |
| Dec 31, 2022 | -279.94 Mn |
| Sep 30, 2022 | -99.73 Mn |
| Jun 30, 2022 | -5.57 Mn |
| Mar 31, 2022 | -35.46 Mn |
| Dec 31, 2021 | -9.90 Mn |
| Sep 30, 2021 | 86.76 Mn |